Company Analysis
Sign in

Mdxhealth Sa (MDXH)

Nasdaq: MDXH · Services-Medical Laboratories · Herstal, BE · filing with the SEC since 2021
Full chart Alerts Compare
Grade5.4
◀ Past 6.1● Present 5.0▶ Future 5.2
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

11 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Mdxhealth Sa’s names, not what it holds today.

Patents granted
11
11 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against none in 2024 and 1 in 2023
Applications published
18
3 of them in 2025
Names they are printed under
3
its own name
By yearGrantedApplications published
'12'13'14'15'16'17'18'19'20'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name3 counted
MDx Health SA its own name
BE, as the owner printed on each patent
11 granted
15 published
MDxHealth SA its own name
named as the applicant on its applications, in BE. 1 more under the same name are not counted (printed in US)
0 granted
2 published
MDxHealth its own name
BE, as the owner printed on each patent. 1 more under the same name are not counted (printed in US)
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Sep 26, 202311,767,563Method for predicting and treating clinically significant prostate cancerBiotechnologyMDx Health SA
Nov 6, 201810,119,166Methods and kits for identifying and adjusting for bias in sequencing of polynucleotide samplesBiotechnologyMDx Health SA
Oct 30, 201810,113,202Method for determining the methylation status of the promoter region of the TWIST1 gene in genomic DNA from bladder cellsPharmaceuticalsMDx Health SA
Aug 21, 201810,053,724Methylation detection of the MGMT promoterPharmaceuticalsMDx Health SA
Mar 28, 20179,605,312Methods of detecting mutations in BRAF and epigenetic changesBiotechnologyMDx Health SA
Jul 12, 20169,388,471Methylation of the GATA4 gene in urine samples as a marker for bladder cancer detectionBiotechnologyMDx Health SA
Jun 21, 20169,371,569Detection and prognosis of cervical cancerBiotechnologyMDx Health SA
Apr 26, 20169,322,065Methods for determining methylation of the TWIST1 gene for bladder cancer detectionPharmaceuticalsMDx Health SA
Jun 9, 20159,050,280Methylation detection of MGMTPharmaceuticalsMDx Health SA
Mar 3, 20158,969,046Methods for detecting epigenetic modificationsBiotechnologyMDx Health SA
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Oct 2, 20252025/0305058Algorithms and Methods for Assessing Late Clinical Endpoints in Prostate CancerBiotechnologyMDx Health SA
Jul 3, 20252025/0215505MGMT EPIGENETIC DEEP-SEQUENCING ASSAYBiotechnologyMDx Health SA
Apr 24, 20252025/0129432Method for Using Gene Expression to Determine Prognosis of Prostate CancerBiotechnologyMDx Health SA
Mar 7, 20242024/0076743Method for Predicting and Treating Clinically Significant Prostate CancerBiotechnologyMDx Health SA
Dec 15, 20222022/0396842METHOD FOR USING GENE EXPRESSION TO DETERMINE PROGNOSIS OF PROSTATE CANCERBiotechnologyMDxHealth SA
Jan 9, 20202020/0010907MGMT EPIGENETIC DEEP-SEQUENCING ASSAYBiotechnologyMDx Health SA
Jul 11, 20192019/0211405METHOD FOR PREDICTING AND TREATING CLINICALLY SIGNIFICANT PROSTATE CANCERBiotechnologyMDx Health SA · patent 11,767,563 granted from it
May 4, 20172017/0121775Detection and Prognosis of Lung CancerBiotechnologyMDxHealth
Nov 17, 20162016/0333423Methylation of the EPB41L3 Gene or the Promoter of the EPB41L3 Gene in a Test Sample Comprising Cervical CellsBiotechnologyMDx Health SA · patent 10,041,128 granted from it
Jul 21, 20162016/0208341Method for Determining the Methylation Status of the Promoter Region of the TWIST1 Gene in Genomic DNA from Bladder CellsPharmaceuticalsMDx Health SA · patent 10,113,202 granted from it
What it applied for, 2024 to 2025: Biotechnology 4.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton MDXH · research, not advice